login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ELEDON PHARMACEUTICALS INC (ELDN) Stock News
USA
- NASDAQ:ELDN -
US28617K1016
-
Common Stock
1.825
USD
-0.3 (-14.32%)
Last: 11/12/2025, 10:33:10 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ELDN Latest News, Press Relases and Analysis
All
Press Releases
2 hours ago - By: Chartmill
- Mentions:
FMFC
GTI
IHS
CTW
...
Top movers in Wednesday's pre-market session
5 days ago - By: Chartmill
- Mentions:
RUBI
STKS
IFRX
YGMZ
...
What's going on in today's after hours session
3 hours ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
3 hours ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
4 hours ago - By: Benzinga
- Mentions:
IRIX
STXS
SI
LUCY
...
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
17 hours ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
17 hours ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
5 days ago - By: Chartmill
- Mentions:
FMFC
GMED
KODK
RUBI
...
What's going on in today's session
5 days ago - By: Benzinga
Eledon Pharmaceuticals' Lead Asset Fails In Mid-Stage Study, But Pushes Forward With Pivotal Study
5 days ago - By: Chartmill
- Mentions:
GMED
KODK
RUBI
BKYI
...
Keep an eye on the top gainers and losers in Friday's session.
5 days ago - By: Chartmill
- Mentions:
GMED
PSIX
KODK
TNDM
...
These stocks are gapping in today's session
5 days ago - By: Chartmill
- Mentions:
OPEN
GMED
FOXF
RUBI
...
Discover the top movers in Friday's pre-market session.
6 days ago - By: Eledon Pharmaceuticals, Inc.
Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting
6 days ago - By: Eledon Pharmaceuticals, Inc.
Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting
7 days ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
a month ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting
a month ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting
2 months ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
2 months ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
3 months ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025
3 months ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025
3 months ago - By: The Motley Fool
Eledon Posts Narrower Loss in Q2
3 months ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
3 months ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
3 months ago - By: Eledon Pharmaceuticals, Inc.
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
3 months ago - By: Eledon Pharmaceuticals, Inc.
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
3 months ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025
4 months ago - By: Eledon Pharmaceuticals, Inc.
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
4 months ago - By: Eledon Pharmaceuticals, Inc.
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
5 months ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
5 months ago - By: Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
Please enable JavaScript to continue using this application.